News Focus
News Focus
Followers 31
Posts 3911
Boards Moderated 0
Alias Born 09/24/2012

Re: Protector post# 158508

Wednesday, 01/29/2014 5:13:02 PM

Wednesday, January 29, 2014 5:13:02 PM

Post# of 347009
CP, regarding: PPHM @NY Academy of Sciences Symposium...

one line jumps off the page to me and that is the Presentation Title:

"Immune Checkpoint Inhibitors; Assessing the Activity of Bavituximab"

Could this presentation show how PPHM plans on testing Phase III subjects to determine they are benefiting?
If so, to me that will be the day they explain why they won't need 2 to 3 years to show the benefit of bavi in Phase III

Perhaps they will only need a couple months? That is why they will need Hockey Stick Patient Enrollment smile

Thoughts?

GLTA SHareholders, cancer Patients, and their families!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y